Bellevue Life Sciences Acquisition Stock (NASDAQ:BLAC)
Previous Close
$6.73
52W Range
$3.01 - $13.40
50D Avg
$10.74
200D Avg
$10.87
Market Cap
$6.98M
Avg Vol (3M)
$15.26K
Beta
0.53
Div Yield
-
BLAC Company Profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.